Cargando…

Patients with questionable penicillin (beta-lactam) allergy: Causes and solutions

Background: In Europe, North America, and Australia, 5% to 10% of the population are now classified as penicillin (β-lactam) allergic. Only ~ 10% of these questionable diagnoses, mostly made in childhood, can be confirmed by allergy diagnostics. Materials and methods: The aim of this review is to sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Brockow, Knut, Wurpts, Gerda, Trautmann, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822521/
https://www.ncbi.nlm.nih.gov/pubmed/35141465
http://dx.doi.org/10.5414/ALX02310E
_version_ 1784646621228695552
author Brockow, Knut
Wurpts, Gerda
Trautmann, Axel
author_facet Brockow, Knut
Wurpts, Gerda
Trautmann, Axel
author_sort Brockow, Knut
collection PubMed
description Background: In Europe, North America, and Australia, 5% to 10% of the population are now classified as penicillin (β-lactam) allergic. Only ~ 10% of these questionable diagnoses, mostly made in childhood, can be confirmed by allergy diagnostics. Materials and methods: The aim of this review is to show causes and consequences as well as recommendations for dealing with the often questionable diagnosis of penicillin (β-lactam) allergy (BLA). Results: An incorrect BLA diagnosis may negatively impact antibiotic treatment needed in the future, by using a less effective antibiotic or using a broad-spectrum antibiotic, for example, further exacerbating the problem of increasing antibiotic resistance. Accordingly, there is growing pressure from antibiotic stewardship programs to critically challenge the BLA diagnosis. Conservatively, a suspected BLA is reviewed by an allergist using medical history, skin testing, laboratory testing, and provocation. This clarification is costly and is not remunerated in the German health care system; that is the reason why this testing is only offered in a few specialized clinics and practically not at all in general practice. In view of thousands of affected patients, additional strategies are needed to treat patients with a low risk of hypersensitivity reaction despite suspected allergy with a β-lactam antibiotic. In recent years, various methods have been proposed to eliminate suspected allergy as promptly as possible and directly before necessary treatment with a β-lactam antibiotic, including standardized history (also in the form of an algorithm), skin test with immediate reading after 15 minutes, or administration of a small test dose. Investigations of small case series and also multi-center studies to date have yielded promising results in terms of feasibility and safety. Conclusion: Of the large number of patients with (questionable) BLA, most have never been tested and – if antibiotic treatment becomes necessary – simply receive an alternative antibiotic. The diagnosis of BLA therefore requires new approaches besides classical allergy testing to critically question BLA.
format Online
Article
Text
id pubmed-8822521
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dustri-Verlag Dr. Karl Feistle
record_format MEDLINE/PubMed
spelling pubmed-88225212022-02-08 Patients with questionable penicillin (beta-lactam) allergy: Causes and solutions Brockow, Knut Wurpts, Gerda Trautmann, Axel Allergol Select Review Article Background: In Europe, North America, and Australia, 5% to 10% of the population are now classified as penicillin (β-lactam) allergic. Only ~ 10% of these questionable diagnoses, mostly made in childhood, can be confirmed by allergy diagnostics. Materials and methods: The aim of this review is to show causes and consequences as well as recommendations for dealing with the often questionable diagnosis of penicillin (β-lactam) allergy (BLA). Results: An incorrect BLA diagnosis may negatively impact antibiotic treatment needed in the future, by using a less effective antibiotic or using a broad-spectrum antibiotic, for example, further exacerbating the problem of increasing antibiotic resistance. Accordingly, there is growing pressure from antibiotic stewardship programs to critically challenge the BLA diagnosis. Conservatively, a suspected BLA is reviewed by an allergist using medical history, skin testing, laboratory testing, and provocation. This clarification is costly and is not remunerated in the German health care system; that is the reason why this testing is only offered in a few specialized clinics and practically not at all in general practice. In view of thousands of affected patients, additional strategies are needed to treat patients with a low risk of hypersensitivity reaction despite suspected allergy with a β-lactam antibiotic. In recent years, various methods have been proposed to eliminate suspected allergy as promptly as possible and directly before necessary treatment with a β-lactam antibiotic, including standardized history (also in the form of an algorithm), skin test with immediate reading after 15 minutes, or administration of a small test dose. Investigations of small case series and also multi-center studies to date have yielded promising results in terms of feasibility and safety. Conclusion: Of the large number of patients with (questionable) BLA, most have never been tested and – if antibiotic treatment becomes necessary – simply receive an alternative antibiotic. The diagnosis of BLA therefore requires new approaches besides classical allergy testing to critically question BLA. Dustri-Verlag Dr. Karl Feistle 2022-02-01 /pmc/articles/PMC8822521/ /pubmed/35141465 http://dx.doi.org/10.5414/ALX02310E Text en © Dustri-Verlag Dr. K. Feistle https://creativecommons.org/licenses/by/2.5/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Brockow, Knut
Wurpts, Gerda
Trautmann, Axel
Patients with questionable penicillin (beta-lactam) allergy: Causes and solutions
title Patients with questionable penicillin (beta-lactam) allergy: Causes and solutions
title_full Patients with questionable penicillin (beta-lactam) allergy: Causes and solutions
title_fullStr Patients with questionable penicillin (beta-lactam) allergy: Causes and solutions
title_full_unstemmed Patients with questionable penicillin (beta-lactam) allergy: Causes and solutions
title_short Patients with questionable penicillin (beta-lactam) allergy: Causes and solutions
title_sort patients with questionable penicillin (beta-lactam) allergy: causes and solutions
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822521/
https://www.ncbi.nlm.nih.gov/pubmed/35141465
http://dx.doi.org/10.5414/ALX02310E
work_keys_str_mv AT brockowknut patientswithquestionablepenicillinbetalactamallergycausesandsolutions
AT wurptsgerda patientswithquestionablepenicillinbetalactamallergycausesandsolutions
AT trautmannaxel patientswithquestionablepenicillinbetalactamallergycausesandsolutions